Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils

Kwon, Young Mi and Gori, Kevin and Park, Naomi and Potts, Nicole and Swift, Kate and Wang, Jinhong and Stammnitz, Maximilian R. and Cannell, Naomi and Baez-Ortega, Adrian and Comte, Sebastien and Fox, Samantha and Harmsen, Colette and Huxtable, Stewart and Jones, Menna and Kreiss, Alexandre and Lawrence, Clare and Lazenby, Billie and Peck, Sarah and Pye, Ruth and Woods, Gregory and Zimmermann, Mona and Wedge, David C. and Pemberton, David and Stratton, Michael R. and Hamede, Rodrigo and Murchison, Elizabeth P. and van de Rijn, Matt (2020) Evolution and lineage dynamics of a transmissible cancer in Tasmanian devils. PLOS Biology, 18 (11). e3000926. ISSN 1545-7885

[thumbnail of file_id=10.1371%2Fjournal.pbio.3000926&type=printable] Text
file_id=10.1371%2Fjournal.pbio.3000926&type=printable - Published Version

Download (2MB)

Abstract

Devil facial tumour 1 (DFT1) is a transmissible cancer clone endangering the Tasmanian devil. The expansion of DFT1 across Tasmania has been documented, but little is known of its evolutionary history. We analysed genomes of 648 DFT1 tumours collected throughout the disease range between 2003 and 2018. DFT1 diverged early into five clades, three spreading widely and two failing to persist. One clade has replaced others at several sites, and rates of DFT1 coinfection are high. DFT1 gradually accumulates copy number variants (CNVs), and its telomere lengths are short but constant. Recurrent CNVs reveal genes under positive selection, sites of genome instability, and repeated loss of a small derived chromosome. Cultured DFT1 cell lines have increased CNV frequency and undergo highly reproducible convergent evolution. Overall, DFT1 is a remarkably stable lineage whose genome illustrates how cancer cells adapt to diverse environments and persist in a parasitic niche.

Item Type: Article
Subjects: Apsci Archives > Biological Science
Depositing User: Unnamed user with email support@apsciarchives.com
Date Deposited: 08 Feb 2023 07:08
Last Modified: 09 Feb 2024 04:02
URI: http://eprints.go2submission.com/id/eprint/96

Actions (login required)

View Item
View Item